1-6 of 350 Activities
In this CME Outfitters live webcast, expert faculty will elucidate the importance of comprehensive therapeutic and supportive care in preventing end-organ damage and improving QoL in patients with SCD. Learners will be guided through determining the effectiveness and challenges of current therapies to address the burden of disease in patients with SCD. Faculty will discuss emerging options in SCD treatment, including the long-term efficacy and safety of new interventions and investigational agents.
In this CME Outfitters live webcast, expert faculty will assess the burden of delayed diagnosis on patients with PBC, review evidence-based strategies for early, non-invasive detection, and discuss contemporary clinical pathways for treatment, including recent FDA-approved options. The program will also emphasize interdisciplinary collaboration and shared decision-making to empower patients and improve health outcomes through informed and equitable care. Learners will be equipped with evidence-based tools to help incorporate diagnostic and treatment approaches at the point of care.
In this CME Outfitters Snack, expert faculty will address the impact of CIDP and common challenges the multidisciplinary healthcare team faces, including disease burden and pathophysiology, guideline best practices for diagnosis and treatment, and emerging biologic treatments.
In this CME Outfitters recorded symposium, expert faculty will review the functions of Fc gamma receptors, CD64 and its connection with IL-23, the molecular attributes of anti–IL-23 therapies, in vivo data on expression of CD64 monocytes, and the most recent clinical trial data differentiating the anti–IL-23 agents. To demonstrate these concepts, animated 3-D models will be included in the educational program and available to attendees.
In this CME Outfitters recorded symposium, expert faculty will guide learners on how to integrate knowledge of the heterogeneity of CD in severity and manifestation into patient assessment and treatment. Learners will be instructed on utilizing alternative diagnostic and evaluation tools beyond colonoscopy for evaluating symptoms in patients with CD. Faculty will model incorporation of histopathologic treatment targets as an objective measure of inflammation in CD to inform clinical decision-making.
In the third activity of this CME Outfitters podcast series on gynecologic cancers, expert faculty will present and discuss the very latest research on treatment of endometrial cancer, including strategies that utilize molecular testing and ICI therapies.
